
The iShares LifePath Target Date 2045 ETF is designed to help investors achieve their retirement objectives. It accomplishes this by investing in a diverse collection of other exchange-traded funds. A key feature is its dynamic adjustment of asset allocation, which automatically rebalances as the designated target year of 2045 draws nearer.
Is ITDE's expense ratio expensive, average, or a steal for its category?
Pro reveals the verdict on a 5-tier spectrum calibrated against ICI 2025 industry averages, with strategy-aware bands so the comparison is meaningful.

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE - Get Free Report) saw a significant decline in short interest in the month of March. As of March 13th, there was short interest totaling 15,745 shares, a decline of 36.0% from the February 26th total of 24,607 shares. Currently, 1.0% of the shares of the company are

The health of the $7 trillion U.S. ETF remains strong, with many advisors and investors pairing ETFs with other investments and new entrants joining the market. BlackRock remains the industry leader and has expanded its lineup with innovative strategies in 2023.

BlackRock is offering target-date exchanged-traded funds aimed at helping people save for their retirement outside of a 401 (K) plan.